In the presented manuscript, a new series of 2-[4-methoxy-3-(5-substituted phenyl-[1,3,4]oxadiazol-2-ylmethoxy)-phenyl]-benzothiazoles () have been synthesized and studied and for their anticonvulsant potential. Maximum electroshocks (MES) and subcutaneous pentylenetetrazol (scPTZ) models have been used for anticonvulsant activity. Auto Dock 4.2 software was used for studies, and the targeted protein was 5IOV.sThe antidepressant activity of selected compounds (most active) was determined as a reduction in locomotor activity through an actophotometer. and studies proved that among all the synthesized compounds, and were the most potent with no neurotoxicity as compared to conventional drugs (phenytoin and phenobarbital). The studies also indicated about different binding interactions of synthetic compounds to localize the binding receptors. The most likely mode of action for these drugs, according to the docking analysis of active compounds with various targets, is their binding to the VGCC and NMDA receptors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851031PMC
http://dx.doi.org/10.1021/acsomega.2c06967DOI Listing

Publication Analysis

Top Keywords

design synthesis
4
synthesis evaluation
4
evaluation benzothiazoles
4
benzothiazoles bearing
4
bearing 134-oxadiazole
4
134-oxadiazole moiety
4
moiety antiepileptic
4
antiepileptic agents
4
agents presented
4
presented manuscript
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!